Literature DB >> 32104770

The impact of organisational change on transfusion practices in perioperative care: an analysis of blood product use following the merger of three London cardiac surgery units to form the Barts Heart Centre.

Sibtain Anwar1, Laura Green2, Jackie Cooper3, Miles Curtis4, Neil Roberts4, Julie Sanders5, Marie Scully6, Victoria Stables6, Ben O'Brien1.   

Abstract

OBJECTIVES: In 2015, three London cardiac centres, with different transfusion infrastructure support, merged to form the Barts Heart Centre. We describe the impact on transfusion rate, blood usage and interoperator variation.
DESIGN: Data was collected on all adult patients undergoing cardiac surgery during 2014 as well as 2016, using the National Institute Cardiovascular Outcomes Research (NICOR) data set.
MEASUREMENTS AND MAIN RESULTS: Over the two time periods, a total of 3,647 cardiac procedures were performed (1,930 in 2014 and 1,717 in 2016). There were no significant differences in type of surgery or patient comorbidity between the two epochs of time. Overall, red blood cell transfusion at 24 hours and until hospital discharge reduced significantly in 2016 (odds ratio 0.77; 95% confidence interval 0.68-0.89; p=0.0002). Interoperator variability (adjusted for comorbidities) reduced after merger from standard deviation 0.394 (standard error (SE) 0.096) to 0.269 (SE 0.082), p=0.001.
CONCLUSION: Clinical and organisational factors can improve transfusion service. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  Patient blood management; cardiac surgery; transfusion services

Year:  2020        PMID: 32104770      PMCID: PMC7032573          DOI: 10.7861/fhj.2019-0014

Source DB:  PubMed          Journal:  Future Healthc J        ISSN: 2514-6645


  8 in total

1.  A liberal strategy of red blood cell transfusion reduces cardiogenic shock in elderly patients undergoing cardiac surgery.

Authors:  Rosana Ely Nakamura; Jean-Louis Vincent; Julia Tizue Fukushima; Juliano Pinheiro de Almeida; Rafael Alves Franco; Clarice Lee Park; Eduardo Atsushi Osawa; Carolina Maria Pinto Silva; Jose Otavio Costa Auler; Giovanni Landoni; Filomena Regina Barbosa Gomes Galas; Roberto Kalil Filho; Ludhmila Abrahao Hajjar
Journal:  J Thorac Cardiovasc Surg       Date:  2015-07-26       Impact factor: 5.209

2.  The modernisation of pathology and laboratory medicine in the UK: networking into the future.

Authors:  Graham H Beastall
Journal:  Clin Biochem Rev       Date:  2008-02

3.  British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding.

Authors:  Laura Green; Paula Bolton-Maggs; Craig Beattie; Rebecca Cardigan; Yiannis Kallis; Simon J Stanworth; Jecko Thachil; Sharon Zahra
Journal:  Br J Haematol       Date:  2018-03-12       Impact factor: 6.998

4.  Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery.

Authors:  Gavin J Murphy; Barnaby C Reeves; Chris A Rogers; Syed I A Rizvi; Lucy Culliford; Gianni D Angelini
Journal:  Circulation       Date:  2007-11-12       Impact factor: 29.690

5.  Liberal or restrictive transfusion after cardiac surgery.

Authors:  Gavin J Murphy; Katie Pike; Chris A Rogers; Sarah Wordsworth; Elizabeth A Stokes; Gianni D Angelini; Barnaby C Reeves
Journal:  N Engl J Med       Date:  2015-03-12       Impact factor: 91.245

6.  Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant.

Authors:  D F O'Shaughnessy; C Atterbury; P Bolton Maggs; M Murphy; D Thomas; S Yates; L M Williamson
Journal:  Br J Haematol       Date:  2004-07       Impact factor: 6.998

7.  Cryoprecipitate use in 25 Canadian hospitals: commonly used outside of the published guidelines.

Authors:  Edward C Alport; Jeannie L Callum; Susan Nahirniak; Bernie Eurich; Heather A Hume
Journal:  Transfusion       Date:  2008-08-28       Impact factor: 3.157

8.  Cryoprecipitate for transfusion: which patients receive it and why? A study of patterns of use across three regions in England.

Authors:  H Tinegate; S Allard; J Grant-Casey; S Hennem; M Kilner; M Rowley; F Seeney; S Stanworth
Journal:  Transfus Med       Date:  2012-05-14       Impact factor: 2.019

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.